About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 247649, 7 pages
http://dx.doi.org/10.1155/2013/247649
Research Article

What Is the Role of Apelin regarding Cardiovascular Risk and Progression of Renal Disease in Type 2 Diabetic Patients with Diabetic Nephropathy?

1Nephrology Department, Hospital Faro, Rua Leão Penedo, 8000-386 Faro, Portugal
2Pathology Clinic, Hospital Faro, 8000-836 Faro, Portugal
3Science of the Sea Department, University of Algarve, 8000-140 Faro, Portugal
4Cardiology Department, Hospital Faro, 8000-386 Faro, Portugal
5Pharmacology Department, Gnostic Laboratory, 8000-307 Faro, Portugal

Received 30 April 2013; Revised 5 August 2013; Accepted 8 August 2013

Academic Editor: Denis Feliers

Copyright © 2013 Ana Paula Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Walatek and W. Sulowicz, “Cardiorenal syndrome–alternate challenge for nephrologist,” Przeglad Lekarski, vol. 68, no. 9, pp. 619–628, 2011. View at Scopus
  2. J. Malyszko, J. S. Malyszko, K. Pawlak, and M. Mysliwiec, “Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure,” Advances in Medical Sciences, vol. 53, pp. 32–36, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. S. Ahima, “Metabolic actions of adipocyte hormones: focus on adiponectin,” Obesity, vol. 14, no. 2, pp. 9–15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Kougias, H. Chai, P. H. Lin, Q. Yao, A. B. Lumsden, and C. Chen, “Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease,” Journal of Surgical Research, vol. 126, no. 1, pp. 121–129, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Małyszko, J. S. Małyszko, P. Koźminski, and M. Myśliwiec, “Apelin and cardiac function in hemodialyzed patients: possible relations?” American Journal of Nephrology, vol. 26, no. 2, pp. 121–126, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Tatemoto, M. Hosoya, Y. Habata et al., “Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor,” Biochemical and Biophysical Research Communications, vol. 251, no. 2, pp. 471–476, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. C. J. Charles, “Putative role for apelin in pressure/volume homeostasis and cardiovascular disease,” Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 5, no. 1, pp. 1–10, 2007. View at Scopus
  8. B. Chandrasekaran, O. Dar, and T. McDonagh, “The role of apelin in cardiovascular function and heart failure,” European Journal of Heart Failure, vol. 10, no. 8, pp. 725–732, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 33, Supplement 1, pp. S62–S69, 2010.
  10. D. R. Matthews, J. P. Hosker, and A. S. Rudenski, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Scopus
  11. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999. View at Scopus
  12. A. M. El-Shehaby, M. M. El-Khatib, A. A. Battah, and A. R. Roshdy, “Apelin: a potential link between inflammation and cardiovascular disease in end stage renal disease patients,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 70, no. 6, pp. 421–427, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. V. O. Leal, J. C. Lobo, M. B. Stockler-Pinto, et al., “Apelin: a peptide involved in cardiovascular risk in hemodialysis patients?” Renal Failure, vol. 34, no. 5, pp. 577–581, 2012. View at Publisher · View at Google Scholar